Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

16.70
BATS BZX Real-Time Price
As of 3:50pm ET
 +0.35 / +2.14%
Today’s Change
12.21
Today|||52-Week Range
18.00
+27.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$891.2M

Company Description

Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer or pain. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its primary products are SUSTOL, HTX-019 and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bio erodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA.

Contact Information

Heron Therapeutics, Inc.
4242 Campus Point Court
San Diego California 92121
P:(858) 251-4400
Investor Relations:
(581) 251-4447

Employees

Shareholders

Other institutional65.32%
Mutual fund holders53.12%
Individual stakeholders15.07%

Top Executives

Barry D. QuartChief Executive Officer & Director
Robert H. RosenPresident, Director & Chief Commercial Officer
Robert E. HoffmanChief Financial Officer & Senior VP-Finance
Thomas B. OttoboniSVP-Pharmaceutical, Research & Development
David L. SzekeresSecretary, Senior Vice President & General Counsel